37.94
3.45
(10.00%)
2.3M
XNAS Volume
XNAS 26 Sep, 2025 1:00 PM (EDT)
FDA Rejection
FDA rejects Scholar Rock's muscle weakness drug, cites issues at third-party manufacturing site
See details